Skip to main content

Sjögren Syndrome clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

    open to eligible people ages 18 years and up

    Primary Objective: To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity. Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS. 2. To evaluate the safety and tolerability of dazodalibep in participants with SS

    La Jolla, California and other locations

Last updated: